BofA Restarts Coverage of 11 Large-cap Biopharmas

Seeking Alpha06:01

Piper Sandler Maintains Regeneron Pharmaceuticals(REGN.US) With Buy Rating, Maintains Target Price $1,195

Futu News04:31 · Ratings

Regeneron Pharmaceuticals (REGN): Sales Struggles and Future Prospects

Yahoo Finance01:04

B of A Securities Reinstates Underperform on Regeneron Pharmaceuticals, Announces $565 Price Target

BenzingaDec 10 20:32 · Ratings

Regeneron Pharmaceuticals Analyst Ratings

BenzingaDec 10 20:31 · Ratings

Regeneron Presents New And Updated Data For Odronextamab At ASH Annual Meeting

BenzingaDec 10 06:48